Abstract
Narrow-Band Ultraviolet B (NB-UVB) in combination with topical therapy is a widely used treatment for non-segmental vitiligo (NSV). The location of the vitiligo lesions is of influence on the potential repigmentation response after therapy. To date however, these differences in therapeutic response between specific anatomical areas of the body have not been fully characterized. This study aimed to evaluate the clinical response NB-UVB therapy in 19 different body regions. A multicentre study of NSV patients starting with NB-UVB therapy was performed in hospitals in Egypt, Singapore and the Netherlands.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
